Outsourcing-Pharma RSS

Medidata inks EDC deal with Roche

nick.taylor@decisionnews.com — Thu, 02 Jul 2009 11:00:00 +0200

Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.

PDS’ new US office has European focus

nick.taylor@decisionnews.com — Thu, 02 Jul 2009 11:00:00 +0200

UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.

Almac’s Craigavon expansion near completion

gareth.macdonald@decisionnews.com — Thu, 02 Jul 2009 11:00:00 +0200

Almac Pharma Services (APS) has finished the first stage of a $15m (€10.6m) expansion programme at its manufacturing facility in Craigavon, Northern Ireland.

Charles River rejigs exec roles and preclinical organisation

gareth.macdonald@decisionnews.com — Thu, 02 Jul 2009 11:00:00 +0200

US CRO Charles River (CRL) has unveiled a raft of executive changes and plans to restructure its PCS unit to provide customers with a more centralised approach to global drug development.

Teva collaborates to save failed drugs

nick.taylor@decisionnews.com — Wed, 01 Jul 2009 11:00:00 +0200

Teva plans to acquire oncology drugs that fail late-stage clinical trials and collaborate with Optimata to "efficiently rescue" the therapeutics and gain regulatory approval.

Phase Forward signs new deal with GSK

gareth.macdonald@decisionnews.com — Wed, 01 Jul 2009 11:00:00 +0200

Data management specialist Phase Forward has landed a “multi-million dollar” clinical trial services contract with GSK.

PSI collaborates with Microfluidics

nick.taylor@decisionnews.com — Wed, 01 Jul 2009 11:00:00 +0200

Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise.

Altus accuses Lonza of breaching contract

nick.taylor@decisionnews.com — Wed, 01 Jul 2009 11:00:00 +0200

Altus Pharmaceuticals has terminated its contract with Lonza over an alleged breach in the agreement to provide active pharmaceutical ingredients (API) for Trizytek (liprotamase).

Covance doubles capacity at Madison site

nick.taylor@decisionnews.com — Tue, 30 Jun 2009 11:00:00 +0200

Covance has doubled the capacity for large-scale, long-term stability and release programmes at its facility in Madison, Wisconsin, US.

Chiltern sets up in Hungary

gareth.macdonald@decisionnews.com — Tue, 30 Jun 2009 11:00:00 +0200

UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.